Huons Installs Ultrasound Neurological Disease Medical Device 'Exablate Neuro' at Samsung Seoul Hospital

Medical device for treating neurological disorders using ultrasound 'Exablate Neuro' (Photo by Huons)

[Asia Economy Reporter Chunhee Lee] The ultrasound-based medical device for treating neurological disorders, 'ExAblate Neuro,' will be installed at Samsung Medical Center.

Huons, the exclusive domestic supplier of ExAblate Neuro, announced on the 5th that brain disease surgeries using ExAblate Neuro will be possible at Samsung Medical Center starting this September. Huons signed a supply contract with Samsung Medical Center in May and is currently proceeding with procedures for equipment installation.

ExAblate Neuro is an innovative medical device developed by the Israeli biotechnology company Insightec, which applied ultrasound technology?previously used only for diagnostics or skin aesthetics?to the treatment of neurological disorders. Unlike traditional brain surgeries that required opening the skull directly, it uses high-intensity focused ultrasound (MRgFUS) to apply heat to specific tissues causing brain dysfunction, employing a 'non-invasive, bloodless surgical method.'

There is no risk of bleeding or infection, and medical staff can monitor the surgical site in real-time through magnetic resonance imaging (MRI) during the procedure, allowing for highly precise surgery with an error margin within 1 mm. The surgery time is short, and patients can quickly return to daily life, reducing psychological burdens.

It has been approved by the U.S. Food and Drug Administration (FDA) as well as in 23 countries worldwide, including Europe and Asia, and is currently operated in 82 major hospitals and medical institutions globally.

Professor Jeong-il Lee of the Neurosurgery Department at Samsung Medical Center said, “This is a new treatment method with proven excellent therapeutic effects worldwide for neurological diseases such as essential tremor.” He added, “We are pleased that Samsung Medical Center is introducing this innovative advanced treatment system.” Huons CEO Ki-an Eom also stated, “Domestic patients can now receive neurological disease treatment using ExAblate Neuro,” and “We will continue to expand access so that more patients can experience this new treatment method.”

This content was produced with the assistance of AI translation services.